Effect of Interferon Therapy on Human Papillomavirus Copy Number in Patients With Condyloma Acuminatum

Interferons exert antiviral, antiproliferative, and immunomodulatory effects on target cells. The effectiveness of interferon treatment can be followed by measuring parameters involved in interferon action. The clinical effectiveness of interferons has been proved in the human papillomavirus (HPV)-associated disease condyloma acuminatum. Because one of the most important goals in the treatment of this condition is the elimination of recurrences, it was asked whether clinically effective interferon therapy was associated with elimination of HPV DNA. The authors used a polymerase chain reaction-based method to detect the HPV from minute amounts of clinical biopsies. Human papillomavirus-transformed cell lines or cloned HPV genomes served as different copy number controls. The intensity ratio of L1 HPV and the human βglobin (which served as an internal control) fragments was determined and used for estimation of HPV copy number in different biopsies. A direct effect of interferon treatment on HPV viral genome copies was observed in a group of responder patients, but not in the clinically resistant group. With these data, a correlation was found between virologic data and clinical findings. This method also can be used in other lesions to determine the HPV copy number and HPV type and may have value in determining the antiviral activities of other agents used in the treatment of HPV-related lesions.

[1]  R. Eckert,et al.  Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes. , 1994, Cancer research.

[2]  W. Dinsmore,et al.  Detection of Human Papillomavirus by the Polymerase Chain Reaction in Histologically Normal Penile Skin Adjacent to Penile Warts , 1994, Sexually transmitted diseases.

[3]  I. Arany,et al.  Interferon treatment enhances the expression of underphosphorylated (biologically-active) retinoblastoma protein in human papilloma virus-infected cells through the inhibitory TGF beta 1/IFN beta cytokine pathway. , 1994, Antiviral research.

[4]  I. Arany,et al.  Direct sequencing of consensus primer generated PCR fragments of human papillomaviruses. , 1993, Journal of virological methods.

[5]  W. Tolleson,et al.  Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons , 1993, Journal of virology.

[6]  B. Katz,et al.  Factors associated with detection of human papillomavirus E4 and L1 proteins in condylomata acuminata. , 1992, The Journal of infectious diseases.

[7]  C. Woodworth,et al.  Leukoregulin and gamma-interferon inhibit human papillomavirus type 16 gene transcription in human papillomavirus-immortalized human cervical cells. , 1992, Cancer research.

[8]  S. Baron,et al.  The interferons. Mechanisms of action and clinical applications. , 1991, JAMA.

[9]  H. Hausen Human papillomaviruses in the pathogenesis of anogenital cancer. , 1991 .

[10]  A. Venuti,et al.  Interferon inhibition of neoplastic phenotype in cell lines harbouring human papillomavirus sequences. , 1991, Journal of biological regulators and homeostatic agents.

[11]  M. Stoler,et al.  Treatment of condyloma acuminatum with three different interferon-alpha preparations administered parenterally: a double-blind, placebo-controlled trial. , 1990, The Journal of infectious diseases.

[12]  H. Fox,et al.  Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. , 1990, Journal of the National Cancer Institute.

[13]  Y. Nishiyama,et al.  Selective suppression of human papilloma virus type 18 mRNA level in HeLa cells by interferon. , 1990, Biochemical and biophysical research communications.

[14]  W. Lancaster,et al.  Amplification of human papillomavirus DNA sequences by using conserved primers , 1989, Journal of clinical microbiology.

[15]  S. Tyring Chemotherapeutic strategies in the multidisciplinary treatment of head and neck cancer. , 1988 .

[16]  E. de Villiers,et al.  Interferon treatment of human genital papillomavirus infection: Importance of viral type , 1987, International journal of cancer.

[17]  A. Ferenczy,et al.  Latent papillomavirus and recurring genital warts. , 1985, The New England journal of medicine.

[18]  I. Arany,et al.  Alterations in cytokine/antioncogene expression in skin lesions caused by "low-risk" types of human papillomaviruses. , 1993, Viral immunology.

[19]  R. Stadler,et al.  Interferons. New additions and indications for use. , 1993, Dermatologic clinics.

[20]  Steven Wolinsky,et al.  The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses , 1989 .